8-K
filed September 12, 2023, 7:59 PM ET
ticker BBLG
CIK 0001419554
other material
confidence high
sentiment neutral
materiality 0.15
Bone Biologics stockholders elect directors and approve all proposals at annual meeting
Bone Biologics Corp
- Four director nominees elected: Hankey, Stroever, Lucera, Angle; broker non-votes of 578,270 for each.
- Advisory vote on executive compensation approved: 904,764 for, 84,094 against, 307,376 abstentions.
- Advisory frequency vote selects every year (958,400 votes); board adopts annual say-on-pay policy.
- Ratification of Weinberg & Company as auditor for FY2023: 1,513,051 for, 61,316 against.
- First Amendment to 2015 Equity Incentive Plan approved: 863,931 for, 123,150 against, 309,153 abstentions.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Bone Biologics Corp shareholders approved Ratification of Weinberg & Company, P.A. as independent auditor at the 2023-09-12 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-09-12
Exact text from the filing
The Company’s stockholders ratified the appointment of Weinberg & Company, P.A. as the Company’s independent registered public accounting firm
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Bone Biologics Corp shareholders approved Advisory vote on executive compensation at the 2023-09-12 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-09-12
Exact text from the filing
The Company’s stockholders approved, on an advisory basis, the Company’s executive compensation.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Bone Biologics Corp shareholders approved Frequency of future say-on-pay votes at the 2023-09-12 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-09-12
Exact text from the filing
The Company’s stockholders approved, on an advisory basis, that future say-on-pay votes should occur every year.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Bone Biologics Corp shareholders approved Approval of First Amendment to 2015 Equity Incentive Plan at the 2023-09-12 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-09-12
Exact text from the filing
The Company’s stockholders approved the First Amendment to the Company’s 2015 Equity Incentive Plan.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Bone Biologics Corp shareholders approved Election of directors at the 2023-09-12 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-09-12
Exact text from the filing
The Company’s stockholders elected the following four director nominees to serve until the date of the next Annual Meeting
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.